Study identifier:D8224C00001
ClinicalTrials.gov identifier:NCT04872621
EudraCT identifier:N/A
CTIS identifier:N/A
Calquence 100 mg capsules General Drug Use-Results Study; All Patient Investigation in patients with relapsed or refractory chronic lymphocytic leukemia (including small lymphocytic lymphoma)
relapsed or refractory Chronic Lymphocytic Leukemia (including Small Lymphocytic Lymphoma)
N/A
No
-
All
104
Observational
n/a - n/a
Allocation: N/A
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verified 01 Aug 2024 by AstraZeneca
AstraZeneca
-
No locations available
Arms | Assigned Interventions |
---|